Bentley Endovascular Group AB
23.11.2023 - 13:20:04Bentley Endovascular Group AB paves the way for the new Bentley Campus by tripling size of its German location
| Bentley Endovascular Group AB / Key word(s): Expansion 23.11.2023 / 13:20 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE Hechingen (Germany) November 23, 2023 +++ The rapidly expanding medical technology Group Bentley via its subsidiary Bentley InnoMed GmbH purchased the entire site of the upholstered leisure furniture manufacturer Best Freizeitmöbel GmbH in Hechingen. The site is directly adjacent to Bentley’s existing company premises. Bentley CEO Sebastian Büchert and the Strobel family, owners of Best Freizeitmoebel GmbH, signed the corresponding agreement today. With this purchase, the European market leader for stents is tripling its site, located in the industrial area between Lotzenäcker and State Highway 410, from 15,000 square meters to almost 45,000 square meters. The previous owner, Best, will gradually hand over the use of the site to Bentley until the middle of 2025. The parties to the agreement have agreed not to disclose the purchase price. Bentley had already acquired a piece of property from Best in 2021, upon which it built the 5-story Bentley parking garage. Bentley CEO Sebastian Büchert is delighted to have this expansion opportunity located right next door. This is due to Bentley’s plan to vastly increase its stent production. The site expansion will also meet the Company’s urgent requirement for new capacity. All other areas in the Company – from logistics to research and development – are also in need of space, which will now be a thing of the past. The foundation has thereby been set for the growth strategy in the years ahead. The old production buildings and warehouses on the Best site will therefore make way for the new Bentley Campus in the years to come. This will change the future face of Lotzenäcker business park in Hechingen, Germany as well as attract new employees. CEO Büchert plans to employ significantly more people by then to accommodate the Company’s dynamic growth. Image subtitle: Bentley paves the way for the new Bentley Campus by tripling the size of its Hechingen Lotzenäcker location (in blue, the existing Bentley premises, marked in red the properties purchased from BEST) About Bentley Endovascular Group AB The medical technology holding company Bentley Endovascular Group AB, headquartered in Stockholm, Sweden, controls its German subsidiary Bentley InnoMed GmbH, as well as Qmedics AG, based in Switzerland. Founded in 2009 by Lars Sunnanväder and Miko Obradovic, Bentley InnoMed GmbH is based in the medical technology stronghold of Hechingen in Baden-Wurttemberg, Germany. The company develops, manufactures, and markets implants and catheters for the endovascular treatment of peripheral vascular and aortic diseases. The company has since then become a leading global manufacturer and the European market leader for covered stents. Acquired in 2023, Qmedics AG is a Swiss specialist in balloon catheters and key supplier to Bentley. In 2022, Bentley InnoMed GmbH, contributing the large part to Group sales, generated sales revenue of approx. EUR 69 million. The Group is on a path of strong but profitable growth based on its product innovations and the development of new markets. Bentley’s products are distributed in more than 80 countries worldwide with more than 400 employees committed to a strong culture of innovation driving the business. The Group is majority owned by the founders, with a minority stake owned by lead investor Keensight Capital alongside A.P. Moller Holding and Bonit Capital. It is an integral part of the Group’s strategy to secure independence as a sustainable organization and self-challenging market leader through healthy organic and inorganic growth.For more information, please visit www.group.bentley.global Contact for further information: Bentley Endovascular Group AB Stephan Haas Corporate Communications Tel +49 7471 98499 5691 Mobile +49 151 14124552 Email S.Haas@bentley.global Website www.bentley.global Jenny Rosberg Investor Relations Schweden Bentley Endovascular Group AB Tel +46 70 747 27 41 E-Mail Jenny.Rosberg@ropa.se 23.11.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com |
| Language: | English |
| Company: | Bentley Endovascular Group AB |
| Box 1432 | |
| SE-11184 Stockholm | |
| Sweden | |
| Internet: | www.bentley-group.global |
| EQS News ID: | 1780503 |
| End of News | EQS News Service |
| |
